Mostrar el registro sencillo del ítem
dc.contributor.author | Marín Pallá, Juan Carlos | es_ES |
dc.contributor.author | Clara Trujillo, Sandra | es_ES |
dc.contributor.author | Cordón, Lourdes | es_ES |
dc.contributor.author | Gallego Ferrer, Gloria | es_ES |
dc.contributor.author | Sempere, Amparo | es_ES |
dc.contributor.author | Gómez Ribelles, José Luís | es_ES |
dc.date.accessioned | 2022-11-21T10:32:36Z | |
dc.date.available | 2022-11-21T10:32:36Z | |
dc.date.issued | 2022-11-21 | |
dc.identifier.uri | http://hdl.handle.net/10251/189950 | |
dc.description.abstract | Multiple myeloma is a hematologic neoplasm caused by an uncontrolled clonal proliferation of neoplastic plasma cells (nPCs) in the bone marrow. The development and survival of this disease is tightly related to the bone marrow environment. Proliferation and viability of nPCs depend on their interaction with the stromal cells and the extracellular matrix components, which also influences the appearance of drug resistance. Recapitulating these interactions in an in vitro culture requires 3D environments that incorporate the biomolecules of interest. In this work, we studied the proliferation and viability of three multiple myeloma cell lines in a microgel consisting of biostable microspheres with fibronectin (FN) on their surfaces. We also showed that the interaction of the RPMI8226 cell line with FN induced cell arrest in the G0/G1 cell cycle phase. RPMI8226 cells developed a significant resistance to dexamethasone, which was reduced when they were treated with dexamethasone and bortezomib in combination. | es_ES |
dc.description.sponsorship | CIBER-BBN is an initiative funded by the VI National R&D&I Plan 2008–2011, Iniciativa Ingenio 2010, and Consolider Program. CIBER Actions were financed by the Instituto de Salud Carlos III, with assistance from the European Regional Development Fund. The kind supplying of RPMI 8226 cells by Beatriz Martin (Josep Carreras Leukaemia Research Institute) is greatly acknowledged. The Microscopy Service of the UPV (Universitat Politècnica de València) is gratefully acknowledged. | es_ES |
dc.language | Inglés | es_ES |
dc.publisher | MDPI | es_ES |
dc.publisher | Universitat Politècnica de València | es_ES |
dc.relation.uri | https://doi.org/10.3390/biomedicines10112797 | |
dc.rights | Reconocimiento (by) | es_ES |
dc.subject | Multiple myeloma | es_ES |
dc.subject | Microgels | es_ES |
dc.subject | Fibronectin | es_ES |
dc.subject | Bortezomib | es_ES |
dc.subject | Dexamethasone | es_ES |
dc.subject.classification | CIENCIA DE LOS MATERIALES E INGENIERIA METALURGICA | es_ES |
dc.title | Protein-Functionalized Microgel for Multiple Myeloma Cells’ 3D Culture | es_ES |
dc.type | Dataset | es_ES |
dc.identifier.doi | 10.4995/Dataset/10251/189950 | es_ES |
dc.relation.projectID | info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020/PID2019-106099RB-C41/ES/MICROGELES BIOMIMETICOS PARA EL ESTUDIO DE LA GENERACION DE RESISTENCIAS A FARMACOS EN EL MIELOMA MULTIPLE/ | es_ES |
dc.relation.projectID | info:eu-repo/grantAgreement/GVA//PROMETEO%2F2016%2F063/ES/MEDULA OSEA ARTIFICIAL PARA PERSONALIZAR EL TRATAMIENTO DE PACIENTES DE CANCERES DE SANGRE/ | es_ES |
dc.rights.accessRights | Abierto | es_ES |
dc.contributor.affiliation | Universitat Politècnica de València. Centro de Biomateriales e Ingeniería Tisular - Centre de Biomaterials i Enginyeria Tissular | es_ES |
dc.description.bibliographicCitation | Marín Pallá, JC.; Clara Trujillo, S.; Cordón, L.; Gallego Ferrer, G.; Sempere, A.; Gómez Ribelles, JL. (2022). Protein-Functionalized Microgel for Multiple Myeloma Cells’ 3D Culture. MDPI. https://doi.org/10.4995/Dataset/10251/189950 | es_ES |
dc.type.version | info:eu-repo/semantics/publishedVersion | es_ES |
dc.contributor.funder | Agencia Estatal de Investigación | es_ES |
dc.contributor.funder | Generalitat Valenciana | es_ES |